Abstract

17123 Background: Precise recognition of N1–2 lymph node metastases (RLN) of non-small cell lung cancer (LC) means great importance in prediction LC patients (LCP) survival after surgery. We examined the immunologic factors associated with LCP with N0 and N1–2. Methods: In trial (1987–2005) the data of consecutive 289 LCP after complete pneumonectomies/lobectomies and mediastinal lymph node dissection (age = 58.1 ± 0.5 years; tumor size = 4.4 ± 0.1 cm; m = 260, f = 29) with pathologic stage I-III (T1–4N0–2M0) (squamous = 169, adenocarcinoma = 102, large cell = 18; G1 = 67, G2 = 110, G3 = 112; T1 = 100, T2 = 114, T3 = 54, T4 = 21; N0 = 147, N1 = 70, N2 = 72; pneumonectomies = 135, bi/lobectomies = 154) was reviewed. Variables selected for ED study were input levels of 64 immunity blood parameters, sex, age. Representativeness of samplings was reached by means of randomisation based on unrepeated random selection. Logistic regression, clustering, discriminant analysis, neural networks computing, structural equation modeling, Monte Carlo and bootstrap simulation were used to determine any significant regularity. Results: Logistic regression modeling displayed that RLN of LC significantly depended on: CDw26, CD16, phagocytic number, ratio of lymphocytes, T-lymphocytes, CD4+2H to LC cells (P = 0.003–0.043). Neural networks computing, genetic algorithm selection and bootstrap simulation revealed relationships between N1–2 and blood IgM (rank = 1), eosinophils (2), T-lymphocytes (3), CD8 (4), phagocytic number (5), CD8+VV (6), CDw26 (7), B-lymphocytes (8), IS2 (9), CD4 (10), CD4+2H (11), NST-A2 (12), monocytes (13), index of thymus function (14), IgA (15). Conclusions: Correct RLN of LC was 79.2% by logistic regression (odds ratio = 15.65), 82.0% by discriminant analysis and 99.6% by neural networks computing (area under ROC curve = 0.99; error = 0.059). No significant financial relationships to disclose.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.